Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Restructuring Costs: 2011-2024

Historic Restructuring Costs for Amicus Therapeutics (FOLD) over the last 6 years, with Sep 2024 value amounting to $3.1 million.

  • Amicus Therapeutics' Restructuring Costs was N/A to $3.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.2 million, marking a year-over-year change of. This contributed to the annual value of $9.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Amicus Therapeutics reported Restructuring Costs of $3.1 million as of Q3 2024, which was down 48.01% from $6.0 million recorded in Q1 2024.
  • Amicus Therapeutics' 5-year Restructuring Costs high stood at $6.0 million for Q1 2024, and its period low was $3.1 million during Q3 2024.
  • Its 1-year average for Restructuring Costs is $4.6 million, with a median of $4.6 million in 2024.